We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Zynex has acquired Kestrel Labs for $31 million, adding the Boulder, Colo.-based company’s laser-based, noninvasive patient monitoring technology to its line of noninvasive devices for pain management and monitoring. Read More
Whatever ground the device industry lost due to the COVID-19 pandemic it has mostly regained, according to GlobalData, a UK-based market analytics company. Read More
Labcorp is buying Personal Genome Diagnostics for up to $575 million, gaining the Baltimore, Md.-based company’s elio range of liquid biopsy and tissue-based products. Read More
DSAART, a devicemaker doing business as Alpha Aesthetics, failed to investigate numerous complaints about its silicone facial and body contouring implants, the FDA said in a warning letter to the Carson City, Nev.-based company. Read More
FDA-authorized antigen tests for the virus that causes COVID-19 appear to work for the omicron variant but they may have less sensitivity for identifying positive samples, the agency said. Read More
For SARS-CoV-2, which causes COVID-19, LumiraDx’s test has a positive agreement of up to 95.5 percent and a negative agreement of up to 99.2 percent with RT-PCR tests, based on clinical data collected up to 12 days after symptom onset. Read More